Drug: Provigil
2006 sales: $727 million
Manufacturer: Cephalon
Safety concern: Warning; Stevens-Johnson syndrome, psychiatric problems
Related Articles:
> FDA warns of Provigil risks. Report [1]
> Cephalon shares tank after Sparlon (Provigil) rejection. Report [2]
> FDA staffers question safety of Provigil for ADHD. Report [3]
Links:
[1] http://www.fiercepharma.com/story/fda-warns-provigil-risks/2007-10-25
[2] http://www.fiercebiotech.com/story/cephalon-shares-tank-after-sparlon-rejection/2006-08-10
[3] http://www.fiercebiotech.com/story/fda-staffers-question-safety-of-sparlon-for-adhd/2006-03-22
[4] http://www.fiercepharma.com/special-reports/5-actos-top-10-warnings-and-recalls
[5] http://www.fiercepharma.com/special-reports/top-10-drug-warnings-and-recalls-2007
[6] http://www.fiercepharma.com/special-reports/7-zelnorm-top-10-warnings-and-recalls